» Articles » PMID: 38867895

Targeting Keystone Species Helps Restore the Dysbiosis of Butyrate-producing Bacteria in Nonalcoholic Fatty Liver Disease

Overview
Journal Imeta
Specialty Biology
Date 2024 Jun 13
PMID 38867895
Authors
Affiliations
Soon will be listed here.
Abstract

The dysbiosis of the gut microbiome is one of the pathogenic factors of nonalcoholic fatty liver disease (NAFLD) and also affects the treatment and intervention of NAFLD. Among gut microbiomes, keystone species that regulate the integrity and stability of an ecological community have become the potential intervention targets for NAFLD. Here, we collected stool samples from 22 patients with nonalcoholic steatohepatitis (NASH), 25 obese patients, and 16 healthy individuals from New York for 16S rRNA gene sequencing. An algorithm was implemented to identify keystone species based on causal inference theories and dynamic intervention simulation. External validation was performed in an independent cohort from California. Eight keystone species in the gut of NAFLD, represented by , and , were identified, which could efficiently restore the microbial composition of the NAFLD toward a normal gut microbiome with 92.3% recovery. These keystone species regulate intestinal amino acid metabolism and acid-base environment to promote the growth of the butyrate-producing Lachnospiraceae and Ruminococcaceae species that are significantly reduced in NAFLD patients. Our findings demonstrate the importance of keystone species in restoring the microbial composition toward a normal gut microbiome, suggesting a novel potential microbial treatment for NAFLD.

Citing Articles

Non-differential gut microbes contribute to hypertension and its severity through co-abundances: A multi-regional prospective cohort study.

Liu L, Zhou Q, Xu T, Deng Q, Sun Y, Fu J Imeta. 2025; 4(1):e268.

PMID: 40027484 PMC: 11865328. DOI: 10.1002/imt2.268.


Mesenchymal stem cell-derived extracellular vesicles attenuate ferroptosis in aged hepatic ischemia/reperfusion injury by transferring miR-1275.

Gong Y, You Q, Yuan X, Zeng F, Zhang F, Xiao J Redox Biol. 2025; 81:103556.

PMID: 39986119 PMC: 11893313. DOI: 10.1016/j.redox.2025.103556.


Predicting nasal diseases based on microbiota relationship network.

Liang Y, Mao J, Qiu T, Li B, Zhang C, Zhang K Sci Prog. 2025; 108(1):368504251320832.

PMID: 39962881 PMC: 11833901. DOI: 10.1177/00368504251320832.


Associations between changes in the gut microbiota and liver cirrhosis: a systematic review and meta-analysis.

Liu Y, Chen Z, Li C, Sun T, Luo X, Jiang B BMC Gastroenterol. 2025; 25(1):16.

PMID: 39806278 PMC: 11727502. DOI: 10.1186/s12876-025-03589-5.


miMatch: a microbial metabolic background matching tool for mitigating host confounding in metagenomics research.

Liu L, Cao S, Lin W, Gao Z, Yang L, Zhu L Gut Microbes. 2024; 16(1):2434029.

PMID: 39601293 PMC: 11610556. DOI: 10.1080/19490976.2024.2434029.


References
1.
Berry D, Widder S . Deciphering microbial interactions and detecting keystone species with co-occurrence networks. Front Microbiol. 2014; 5:219. PMC: 4033041. DOI: 10.3389/fmicb.2014.00219. View

2.
Jiao N, Loomba R, Yang Z, Wu D, Fang S, Bettencourt R . Alterations in bile acid metabolizing gut microbiota and specific bile acid genes as a precision medicine to subclassify NAFLD. Physiol Genomics. 2021; 53(8):336-348. PMC: 8424563. DOI: 10.1152/physiolgenomics.00011.2021. View

3.
Friedman J, Alm E . Inferring correlation networks from genomic survey data. PLoS Comput Biol. 2012; 8(9):e1002687. PMC: 3447976. DOI: 10.1371/journal.pcbi.1002687. View

4.
Walker A, Duncan S, McWilliam Leitch E, Child M, Flint H . pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Appl Environ Microbiol. 2005; 71(7):3692-700. PMC: 1169066. DOI: 10.1128/AEM.71.7.3692-3700.2005. View

5.
Caussy C, Hsu C, Lo M, Liu A, Bettencourt R, Ajmera V . Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD. Hepatology. 2018; 68(3):918-932. PMC: 6151296. DOI: 10.1002/hep.29892. View